Given that CDK6 upregulation was found in lenalidomide-resistant patients and induced expression reduced lenalidomide-sensitivity, we next tested the effects of the CDK6 inhibitor palbociclib36,37 in multiple myeloma cell lines. The gene discussed is CDK6; the disease is AL amyloidosis.